(Q39341635)

11 September 2017

Regulation of hepatitis C virus translation initiation by iron: role of eIF3 and La protein (English)

1 reference

11 September 2017

1 reference

Qiang Wang

1

1 reference

11 September 2017

Yiping Liu

2

1 reference

11 September 2017

Daizhi An

3

1 reference

11 September 2017

Hongyan Diao

4

1 reference

11 September 2017

Wei Xu

5

1 reference

11 September 2017

Xiang He

6

1 reference

11 September 2017

Rubao Sun

7

1 reference

11 September 2017

Li Wei

8

1 reference

11 September 2017

Lanjuan Li

9

1 reference

11 September 2017

24 May 2012

1 reference

11 September 2017

1 reference

11 September 2017

167

1 reference

11 September 2017

2

1 reference

11 September 2017

302-309

1 reference

The La antigen binds 5' noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.05.014

Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.05.014

Distinct regions of human eIF3 are sufficient for binding to the HCV IRES and the 40S ribosomal subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.05.014

Iron increases translation initiation directed by internal ribosome entry site of hepatitis C virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.05.014

Heterogeneous nuclear ribonucleoprotein I (hnRNP-I/PTB) selectively binds the conserved 3' terminus of hepatitis C viral RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.05.014

Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: a meta-analysis of six prospective randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.05.014

Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.05.014

EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.05.014

Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.05.014

Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.05.014

Iron depletion is not effective in inducing a virologic response in patients with chronic hepatitis C who failed to respond to interferon therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.05.014

La protein is a potent regulator of replication of hepatitis C virus in patients with chronic hepatitis C through internal ribosomal entry site-directed translation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.05.014

Chronic hepatitis C and diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.05.014

Iron supplementation generates hydroxyl radical in vivo. An ESR spin-trapping investigation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.05.014

Mechanism of ribosome recruitment by hepatitis C IRES RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.05.014

Recognition of nascent RNA by the human La antigen: conserved and divergent features of structure and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.05.014

Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.05.014

Factors affecting treatment responses to interferon-alpha in chronic hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.05.014

A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.05.014

Iron, oxidative stress and liver fibrogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.05.014

Inhibition of internal ribosomal entry site-directed translation of HCV by recombinant IFN-alpha correlates with a reduced La protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.05.014

Poly(C)-binding protein interacts with the hepatitis C virus 5' untranslated region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.05.014

Iron regulates hepatitis C virus translation via stimulation of expression of translation initiation factor 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.05.014

Response to interferon alpha therapy is influenced by the iron content of the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2012.05.014

10.1016/J.VIRUSRES.2012.05.014

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference